Skip to main content
Clinical Trials/NCT01615770
NCT01615770
Completed
Not Applicable

Behavioral Maintenance Treatment for Smoking Cessation

Stanford University2 sites in 1 country304 target enrollmentFebruary 2004
ConditionsSmoking

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking
Sponsor
Stanford University
Enrollment
304
Locations
2
Primary Endpoint
expired-air carbon monoxide confirmed 7-day point prevalence smoking abstinence
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Our primary goal is to examine the effectiveness of a multi-factor maintenance treatment strategy in promoting longer-term smoking abstinence. The investigators will also conduct secondary analyses of mediators and moderators of treatment response.

Detailed Description

400 adult smokers will be randomized. Our primary goal is to examine the effectiveness of a multi-factor maintenance treatment strategy in promoting longer-term smoking abstinence. All smokers will receive the same "Acute Phase Treatment" that combines nicotine patch, bupropion and intensive self-regulatory skills training. Nicotine patches will be provided for 8 weeks and bupropion and skills training will be provided for of 9 weeks. Participants will then enter a "Maintenance Treatment Phase" during which half (n=200) will receive three individualized relapse prevention training sessions spread over a 12 week period. They will also receive 12 weeks of self-administered RPT administered via written treatment modules. Finally, telephone counseling will be provided in conjunction with an Interactive Voice Response system (IVR) that will allow early detection of smoking "slips" and rapid response by treatment staff. The other half (n=200) will be assigned to a control condition that consists of three counselor-led sessions of "supportive therapy" spread over a 12 week period.

Registry
clinicaltrials.gov
Start Date
February 2004
End Date
June 2009
Last Updated
10 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joel D Killen

Principle Investigator

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Healthy adult cigarette smokers smoking at least 10 cigarettes per day

Exclusion Criteria

  • Currently pregnant
  • Currently breastfeeding
  • Currently diagnosed with a seizure disorder, major depression, liver disease, kidney disease, congestive heart failure
  • History of a seizure, seizure disorder, significant head trauma or central nervous system tumor
  • Family history of seizures
  • Currently using intravenous drugs
  • Currently using any drugs (marijuana, alcohol, cocaine, opiates, stimulants, etc.) on a daily basis
  • Currently using any over-the-counter stimulants and anorectics (diet pills)
  • Currently on bupropion (Wellbutrin, Wellbutrin SR) or other antidepressants, monoamine oxidase inhibitors, antipsychotics, benzodiazepines, theophylline, systemic steroids or levodopa
  • Currently on NRT or bupropion (Zyban)

Outcomes

Primary Outcomes

expired-air carbon monoxide confirmed 7-day point prevalence smoking abstinence

Time Frame: 52 weeks

expired-air carbon monoxide \< 10 ppm and self report of no smoking for 7 consecutive days prior to assessment

Secondary Outcomes

  • depression symptoms(52 weeks)

Study Sites (2)

Loading locations...

Similar Trials